Lazard Asset Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-621
| Closed | -$32K | – | 1905 |
|
|
2025
Q2 | $32K | Buy |
621
+88
| +17% | +$4.83K | ﹤0.01% | 2071 |
|
|
2025
Q1 | $32K | Sell |
533
-14,519
| -96% | -$936K | ﹤0.01% | 2067 |
|
|
2024
Q4 | $1.03M | Buy |
15,052
+5,800
| +63% | +$404K | ﹤0.01% | 1138 |
|
|
2024
Q3 | $665K | Buy |
9,252
+5,032
| +119% | +$355K | ﹤0.01% | 1266 |
|
|
2024
Q2 | $292K | Buy |
4,220
+2,498
| +145% | +$182K | ﹤0.01% | 1436 |
|
|
2024
Q1 | $137K | Buy |
+1,722
| New | +$153K | ﹤0.01% | 1426 |
|
|
2023
Q2 | – | Sell |
-2,033
| Closed | -$211K | – | 2338 |
|
|
2023
Q1 | $211K | Buy |
2,033
+1,247
| +159% | +$121K | ﹤0.01% | 1297 |
|
|
2022
Q4 | $69K | Hold |
786
| – | – | ﹤0.01% | 1665 |
|
|
2022
Q3 | $63K | Hold |
786
| – | – | ﹤0.01% | 1689 |
|
|
2022
Q2 | $75K | Sell |
786
-45,834
| -98% | -$5.5M | ﹤0.01% | 1624 |
|
|
2022
Q1 | $6.92M | Sell |
46,620
-10,182
| -18% | -$1.42M | 0.01% | 696 |
|
|
2021
Q4 | $8.05M | Buy |
56,802
+56,441
| +15,635% | +$7.99M | 0.01% | 688 |
|
|
2021
Q3 | $47K | Buy |
+361
| New | +$47.2K | ﹤0.01% | 1705 |
|
|
2021
Q2 | – | Sell |
-3,485
| Closed | -$455K | – | 1975 |
|
|
2021
Q1 | $455K | Sell |
3,485
-4,506
| -56% | -$542K | ﹤0.01% | 994 |
|
|
2020
Q4 | $894K | Buy |
7,991
+7,658
| +2,300% | +$725K | ﹤0.01% | 910 |
|
|
2020
Q3 | $26K | Sell |
333
-282
| -46% | -$23K | ﹤0.01% | 1364 |
|
|
2020
Q2 | $44K | Sell |
615
-21,015
| -97% | -$1.46M | ﹤0.01% | 1257 |
|
|
2020
Q1 | $1.24M | Buy |
21,630
+13,350
| +161% | +$1.23M | ﹤0.01% | 721 |
|
|
2019
Q4 | $925K | Buy |
8,280
+1,615
| +24% | +$172K | ﹤0.01% | 758 |
|
|
2019
Q3 | $640K | Buy |
6,665
+2,074
| +45% | +$195K | ﹤0.01% | 795 |
|
|
2019
Q2 | $392K | Buy |
+4,591
| New | +$377K | ﹤0.01% | 964 |
|
Other funds holding CNMD
WHG
SAM
